You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Merck
Boehringer Ingelheim
McKesson
Mallinckrodt

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Citalopram hydrobromide - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for citalopram hydrobromide and what is the scope of patent protection?

Citalopram hydrobromide is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Forest Labs, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Hikma, Lannett Co Inc, Pharm Assoc, Biovail Labs Intl, Allergan, Amneal Pharms Ny, Apotex Inc, Aurobindo, Chartwell Molecular, Cosette, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Generics, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, Torpharm, and Torrent Pharms, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-six drug master file entries for citalopram hydrobromide. Forty-five suppliers are listed for this compound.

Drug Prices for citalopram hydrobromide

See drug prices for citalopram hydrobromide

Drug Sales Revenue Trends for citalopram hydrobromide

See drug sales revenues for citalopram hydrobromide

Recent Clinical Trials for citalopram hydrobromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
Haining Health-Coming Biotech Co., Ltd.Phase 2
National Institute of Mental Health (NIMH)N/A

See all citalopram hydrobromide clinical trials

Pharmacology for citalopram hydrobromide
Medical Subject Heading (MeSH) Categories for citalopram hydrobromide

US Patents and Regulatory Information for citalopram hydrobromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077141-002 Apr 10, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Fosun Pharma CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077040-003 Aug 17, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Allergan CELEXA citalopram hydrobromide TABLET;ORAL 020822-002 Jul 17, 1998 AB RX Yes No   Start Trial   Start Trial   Start Trial
Amneal Pharms Ny CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077289-002 Nov 30, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077052-003 Jul 3, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077031-002 Oct 28, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Roxane CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077041-001 Nov 23, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Merck
Boehringer Ingelheim
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.